Overview

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
To Observe and Evaluate the Efficacy and Safety of Apatinib in Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Anhui Provincial Hospital
Treatments:
Apatinib